Novel HER2–targeted therapies for HER2–positive metastatic breast cancer
Novel HER2–targeted therapies for HER2–positive metastatic breast cancer is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Novel HER2–targeted therapies for HER2–positive metastatic breast cancer have?
Novel HER2–targeted therapies for HER2–positive metastatic breast cancer has 217 citations in the OpenAlex counts ScholarIQ stores.
When was Novel HER2–targeted therapies for HER2–positive metastatic breast cancer published?
Novel HER2–targeted therapies for HER2–positive metastatic breast cancer has 2020 year in the ScholarIQ index.
What is the open-access status of Novel HER2–targeted therapies for HER2–positive metastatic breast cancer?
Novel HER2–targeted therapies for HER2–positive metastatic breast cancer has bronze oa status in the ScholarIQ index.
What is the DOI of Novel HER2–targeted therapies for HER2–positive metastatic breast cancer?
The DOI for Novel HER2–targeted therapies for HER2–positive metastatic breast cancer is on the source record.
What is the PMID of Novel HER2–targeted therapies for HER2–positive metastatic breast cancer?
The PMID for Novel HER2–targeted therapies for HER2–positive metastatic breast cancer is on the source record.
What is the OpenAlex record for Novel HER2–targeted therapies for HER2–positive metastatic breast cancer?
The OpenAlex for Novel HER2–targeted therapies for HER2–positive metastatic breast cancer is on the source record.